GloriaSanclemente, RuthMurphy, JavierContreras, MónicaRengifo-Pardo, HermenegildoGarcía, XavierBonfill Cosp, GloriaSanclemente. Anti-TNF agents for paediatric psoriasis. 2012. /Sanclemente G, Murphy R, Contreras J, Garcia H, Bonfill Cosp X. Anti-TNF agents for paediatric psoriasis. Cochrane...
Abstract: Treatment of rheumatoid arthritis (RA) patients with anti-tumor necrosis factor-alpha (anti-TNF-α) biologic agents has been associated with a reduction in the levels of specific autoantibodies, such as rheumatoid factor (RF) and anticyclic citrullinated peptide (anti-CCP), and the indu...
Biologic therapy involving anti-tumor necrosis factor-α (anti-TNFα) agents has fundamentally changed the management of patients with immune-media
Anti-TNF agents in famil- ial Mediterranean fever: report of three cases and review of the literature. Mod Rheumatol 2011; 21: 684-90.S. Ozgocmen and O. Akgul, "Anti-TNF agents in Familial Mediterranean fever: report of three cases and review of the literature," Modern Rheumatology, vol...
Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Transmembrane TNF-alpha, a precursor of the soluble form of TNF-alpha, is expressed on activated macrophages and lymphocytes as well as other cell types. After processing by TNF-alpha-converting enzyme (TACE), the...
结论用外用TNFα外科手术都有是依那西普抑制剂外科手术自身特异性眼疾症的病变忧郁症CD或UC的不确定性增加。原始说是:Joshua Korzenik. Et al. Increased risk of developing Crohn’s disease or ulcerative colitis in 17018 patients while under treatment with anti‐TNFα agents, particularly etanercept, for...
结论用抗击TNFα小儿患除此以外是依那西普口服小儿患自身性疾小儿结核小儿的小儿变精神小儿CD或UC的危险性上升。原始应是:Joshua Korzenik. Et al. Increased risk of developing Crohn’s disease or ulcerative colitis in 17018 patients while under treatment with anti‐TNFα agents, particularly etanercept, ...
Thus, TNF-alpha blockers seem to be a major breakthrough in the treatment of SpA. The patients who are primary candidates for such treatments are yet to be defined, particularly in light of the high costs and unknown long-term side effects involved. Furthermore, future studies need to show...
结论用促TNFα疗程特别是依那西普用药疗程自身免疫性哮喘的病人脑癌CD或UC的风险缩减。原始出处:Joshua Korzenik. Et al. Increased risk of developing Crohn’s disease or ulcerative colitis in 17018 patients while under treatment with anti‐TNFα agents, particularly etanercept, for autoimmune diseases ...
结论用抗TNFα特别是依那西普药物治疗自身免疫性疾病的患者CD或UC风险增加。原始来源:JoshuaKorzenik.Etal.IncreasedriskofdevelopingCrohn’sdiseaseorulcerativecolitisin17018patientswhileundertreatmentwithanti‐TNFαagents,particularlyetanercept,forautoimmunediseasesotherthaninflammatoryboweldisease.AlimentaryPharmacology&...